Boncz I, Sebestyén A, Döbrossy L, Péntek Z, Budai A, Kovács A, Dózsa C, Ember I
Department of Health Policy, National Health Insurance Fund Administration, Váci út 73/A., 1139 Budapest, Hungary.
Ann Oncol. 2007 Apr;18(4):795-9. doi: 10.1093/annonc/mdl489. Epub 2007 Jan 27.
The aim of this paper is to give an overview of organisational issues of the Hungarian nationwide organised breast cancer screening programme and to provide the results of the first screening round of the programme for the years 2002-2003.
Data were derived from the financial database of the National Health Insurance Fund Administration covering the period 2000-2003. Women who underwent mammography screening were included into the study.
Uptake of the organised screening programme in 2002-2003 was 45.09%, while the recall rate was 7.23%. Malignant cases represented 65.38% of total surgeries and 0.36% of total number of screened women yielding a cancer detection rate 3.6 per 1000 screened women. Malignant cases of 10.78% were identified as ductal carcinoma in situ, while 89.22% was invasive cancer. Benign to malignant ratio was 0.54 : 1.
There is therefore an urgent need to closely monitor performance and to review programme policies and procedures with the aim of increasing both the participation rate and the proportion of women eligible to attend screening.
本文旨在概述匈牙利全国性有组织的乳腺癌筛查项目的组织问题，并提供该项目2002 - 2003年首轮筛查的结果。
数据来源于国家健康保险基金管理局2000 - 2003年期间的财务数据库。纳入接受乳腺钼靶筛查的女性进行研究。
2002 - 2003年有组织筛查项目的参与率为45.09%，召回率为7.23%。恶性病例占手术总数的65.38%，占筛查女性总数的0.36%，癌症检出率为每1000名筛查女性中有3.6例。10.78%的恶性病例被确定为原位导管癌，89.22%为浸润性癌。良性与恶性比例为0.54 : 1。
因此，迫切需要密切监测项目执行情况，并审查项目政策和程序，以提高参与率和符合筛查条件女性的比例。
